JP2004509099A5 - - Google Patents

Download PDF

Info

Publication number
JP2004509099A5
JP2004509099A5 JP2002526762A JP2002526762A JP2004509099A5 JP 2004509099 A5 JP2004509099 A5 JP 2004509099A5 JP 2002526762 A JP2002526762 A JP 2002526762A JP 2002526762 A JP2002526762 A JP 2002526762A JP 2004509099 A5 JP2004509099 A5 JP 2004509099A5
Authority
JP
Japan
Prior art keywords
halo
alkyl
amino
substituted
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002526762A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004509099A (ja
JP5009480B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/028673 external-priority patent/WO2002022562A1/en
Publication of JP2004509099A publication Critical patent/JP2004509099A/ja
Publication of JP2004509099A5 publication Critical patent/JP2004509099A5/ja
Application granted granted Critical
Publication of JP5009480B2 publication Critical patent/JP5009480B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002526762A 2000-09-15 2001-09-15 一酸化窒素合成阻害剤として有用な2−アミノ−2−アルキル−5−ヘプテン酸及びヘプチン酸誘導体 Expired - Fee Related JP5009480B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23268300P 2000-09-15 2000-09-15
US60/232,683 2000-09-15
PCT/US2001/028673 WO2002022562A1 (en) 2000-09-15 2001-09-15 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors

Publications (3)

Publication Number Publication Date
JP2004509099A JP2004509099A (ja) 2004-03-25
JP2004509099A5 true JP2004509099A5 (cg-RX-API-DMAC7.html) 2008-10-30
JP5009480B2 JP5009480B2 (ja) 2012-08-22

Family

ID=22874118

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002526762A Expired - Fee Related JP5009480B2 (ja) 2000-09-15 2001-09-15 一酸化窒素合成阻害剤として有用な2−アミノ−2−アルキル−5−ヘプテン酸及びヘプチン酸誘導体

Country Status (26)

Country Link
US (2) US6951889B2 (cg-RX-API-DMAC7.html)
EP (1) EP1317421B1 (cg-RX-API-DMAC7.html)
JP (1) JP5009480B2 (cg-RX-API-DMAC7.html)
KR (1) KR100840981B1 (cg-RX-API-DMAC7.html)
CN (1) CN1301966C (cg-RX-API-DMAC7.html)
AR (1) AR030741A1 (cg-RX-API-DMAC7.html)
AT (1) ATE289587T1 (cg-RX-API-DMAC7.html)
AU (2) AU2001290883A1 (cg-RX-API-DMAC7.html)
BR (1) BR0113925A (cg-RX-API-DMAC7.html)
CA (1) CA2421504C (cg-RX-API-DMAC7.html)
CY (1) CY1106056T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ2003646A3 (cg-RX-API-DMAC7.html)
DE (1) DE60109046T2 (cg-RX-API-DMAC7.html)
DK (1) DK1317421T3 (cg-RX-API-DMAC7.html)
EA (1) EA006244B1 (cg-RX-API-DMAC7.html)
ES (1) ES2238477T3 (cg-RX-API-DMAC7.html)
IL (2) IL154841A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03002207A (cg-RX-API-DMAC7.html)
MY (1) MY131964A (cg-RX-API-DMAC7.html)
NO (1) NO20031140L (cg-RX-API-DMAC7.html)
NZ (1) NZ524562A (cg-RX-API-DMAC7.html)
PL (1) PL207391B1 (cg-RX-API-DMAC7.html)
PT (1) PT1317421E (cg-RX-API-DMAC7.html)
SI (1) SI1317421T1 (cg-RX-API-DMAC7.html)
TW (1) TWI290130B (cg-RX-API-DMAC7.html)
WO (1) WO2002022562A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR032318A1 (es) * 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7312044B2 (en) 2003-03-07 2007-12-25 The Trustees Of Columbia University In The City Of New York Type 1 ryanodine receptor-based methods
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US7393652B2 (en) 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US7718644B2 (en) 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
AU2003232148A1 (en) * 2002-05-16 2003-12-02 Pharmacia Corporation A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
CN1652843A (zh) * 2002-05-16 2005-08-10 法玛西雅公司 使用选择性iNOS抑制剂治疗呼吸系统疾病和病症
KR20050059051A (ko) * 2002-08-02 2005-06-17 파마시아 코포레이션 위장 증상의 치료 및 예방 방법
ES2384969T3 (es) 2002-08-23 2012-07-16 Pharmacia Corporation Forma sólida cristalina del ácido (2S-5Z)-2-amino-7-(etanimidoilamino)-2-metilhept-5-enoico
US7544678B2 (en) 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
US20040235139A1 (en) * 2002-12-23 2004-11-25 Demain Arnold L. Clostridium difficile culture and toxin production methods
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
CA2611105A1 (en) * 2005-06-09 2006-12-21 Mallinckrodt Inc. Method for separation and purification of naltrexone by preparative chromatography
US7704990B2 (en) 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
AR059224A1 (es) * 2006-01-31 2008-03-19 Jerini Ag Compuestos para la inhibicion de integrinas y uso de estas
US9895324B2 (en) * 2014-03-26 2018-02-20 University Of Kentucky Research Foundation Halogenated diarylacetylenes and methods of treating cancer
GB201512635D0 (en) 2015-07-17 2015-08-26 Ucl Business Plc Uses of therapeutic compounds
EP3398941A1 (en) * 2017-05-03 2018-11-07 AXXAM S.p.A. Heterocyclic p2x7 antagonists
CN113861064B (zh) * 2021-10-14 2024-05-10 南京医科大学 一类神经保护剂及其药物用途
CN116693389B (zh) * 2023-06-15 2025-09-23 新元果业(山东)集团有限公司 一种合成番茄潜叶蛾性信息素(3e,8z)-3,8-十四碳二烯乙酸酯的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132453A (en) 1991-03-22 1992-07-21 Cornell Research Foundation, Inc. N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9203347D0 (en) 1992-02-17 1992-04-01 Wellcome Found Hypolipidaemic compounds
EP0751930B1 (en) 1994-03-24 2000-01-05 G.D. SEARLE & CO. Amidino derivatives useful as nitric oxide synthase inhibitors
US5994391A (en) 1994-09-13 1999-11-30 G.D. Searle And Company Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US5684008A (en) 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
GB9516709D0 (en) 1995-08-15 1995-10-18 Zeneca Ltd Medicament
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
PL198503B1 (pl) 1998-10-27 2008-06-30 Abbott Lab Związki pirydazynonowe, kompozycje farmaceutyczne je zawierające oraz ich zastosowanie

Similar Documents

Publication Publication Date Title
CA2421504A1 (en) 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
CN108738320B (zh) 用于治疗心血管疾病的cGMP调节剂
JP2002520316A5 (cg-RX-API-DMAC7.html)
CN107406422A (zh) 作为sGC刺激剂的吡唑衍生物
GEP20063875B (en) Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
US12215111B2 (en) Imidazopyridazine IL-17 inhibitor compounds
JP2005519851A (ja) 早漏の治療のためのホスホジエステラーゼインヒビターの投与
HUT76923A (hu) Muszkarinreceptorokra alloszterikus hatást kifejtő heterociklusos vegyületek
JP2008508214A (ja) 女性の性障害の治療用ピペラジン誘導体
TW201010990A (en) New combination-408
JP2005511547A5 (cg-RX-API-DMAC7.html)
JP2004520296A5 (cg-RX-API-DMAC7.html)
JP2004509097A (ja) 酸化窒素シンターゼ阻害剤として有用な2−アミノ−2−アルキル−4ヘキセン酸及びヘキシン酸誘導体
JP2005511697A5 (cg-RX-API-DMAC7.html)
JP2010526801A5 (cg-RX-API-DMAC7.html)
US20200188364A1 (en) Antifungal compounds
JP2023522725A5 (cg-RX-API-DMAC7.html)
US9029405B2 (en) 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate(SIP)receptors
JP2005500370A5 (cg-RX-API-DMAC7.html)
JP2005532321A (ja) 呼吸器の疾患および状態の、選択的iNOS阻害剤とPDE阻害剤による治療方法、ならびにそのための組成物
CN101102989B (zh) 用于治疗高眼压的取代的环戊烷或环戊酮
JP2005501847A5 (cg-RX-API-DMAC7.html)
JP2006512321A5 (cg-RX-API-DMAC7.html)
JP2004517850A5 (cg-RX-API-DMAC7.html)
CN1297431A (zh) 用作多巴胺受体的苯磺酰胺-苯乙胺